Latest Prescription Drugs news
Long-Term Efficacy for Lebrikizumab Seen in Moderate, Severe Eczema
posted October 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Anti-TL1A Monoclonal Antibody, Tulisokibart, Aids Ulcerative Colitis
posted October 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Rheumatoid Arthritis Tied to Heavy Economic and Human Burdens
posted October 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
CDC: Counterfeit Drugs From Online Pharmacies Pose Considerable Danger
posted October 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL 
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors 
Anifrolumab Tied to Lower Hospitalization, Infection Risk in Lupus .jpg)
Recommendations Updated for Management of Anemia in CKD 
Therapies Compared for Newly Diagnosed Multiple Sclerosis 
Initial Rx Length Tied to Long-Term Use of Z-Drugs 
Azacitidine + Venetoclax Tied to Improved Event-Free Survival in Adults With AML 
Updated Recommendations Address Medications to Prevent Migraine in Adults Monthly Specialist Briefings
Stay Connected
